Glycoside Hydrolase Inhibitors

All categories
DBCAT000670Therapeutic categoryA10BF

Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and APHA-GLUCOSIDASES. A DrugBank category of 5 drugs. 3 of them are approved.

ATC classification
Also known as
alpha Amylase Inhibitors, Pancreatic · alpha Glucosidase Inhibitors · alpha-Amylase Inhibitors, Intestinal · alpha-Amylase Inhibitors, Pancreatic · alpha-Glucosidase Inhibitors
Drugs

What you can answer from here — as of January 27, 2021

5DrugsEach linked to its full drug card
Listed above
8Drug targetsEvery drug–target pair in the class, with bond type
Sign in
316Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Glycoside Hydrolase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In